TNF-α (tumor necrosis factor-alpha) is a key cytokine that is elevated in both conditions, which is known to inhibit insulin receptor signaling by inducing the serine phosphorylation of insulin receptor substrate-1 (IRS-1), leading to reduced glucose uptake and systemic insulin resistance [15]. The gene discussed is IRS1; the disease is Insulin resistance.